Milbank LLP represented the financing sources in connection with senior secured credit facilities to support Advent International and Warburg Pincus’ formation of Simtra BioPharma Solutions.
Simtra is an independent customized aseptic fill-finish contract manufacturer focused on complex parenteral (i.e. injectable / infusion) branded drugs for the biopharmaceutical industry.
The Milbank team was led by New York-based Global Leveraged Finance partners Marcus Dougherty and Charles Stern along with associates Emily Rutcofsky, Patrick Sobchak, Edwin Bogert and James Wang.
